Morgan Stanley’s Evotec EVO Stock Holding History
Bought
Maintained
Sold
Other funds holding EVO
MIC
DA
AA
Morgan Stanley's EVO Position: Q1 2026 in Review
Morgan Stanley increased its Evotec (EVO) stake by 0.06% in Q1 2026, buying an estimated $496 and bringing the position to 259,744 shares worth $649K. The position accounts for ﹤0.01% of the portfolio, ranked #5351.
Morgan Stanley first reported a position in EVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.62M in Q2 2025. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.
- Morgan Stanley held 259,744 shares of Evotec worth $649K as of Q1 2026.
- Morgan Stanley bought 154 Evotec shares in Q1 2026, an estimated $496.
- Evotec made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5351 holding.
- Morgan Stanley first reported a position in Evotec in Q4 2021 and has held it in 18 quarters since.
- Morgan Stanley's Evotec position peaked at $1.62M in Q2 2025.
- 46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.